Evidence map›Paper›PMID 38815485›Full record

ReviewComputers in biology and medicine2024

Deep learning reveals lung shape differences on baseline chest CT between mild and severe COVID-19: A multi-site retrospective study.

Amogh Hiremath, Vidya Sankar Viswanathan, Kaustav Bera, Rakesh Shiradkar, Lei Yuan, Keith Armitage, Robert Gilkeson, Mengyao Ji, Pingfu Fu, Amit Gupta and 2 more

Abstract readMulticenter StudyReview
In one paragraph

Review in Computers in biology and medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amogh HiremathCase Western Reserve University, Department of Biomedical Engineering, Cleveland, OH, USA; Picture Health, Cleveland, OH, USA.
Vidya Sankar ViswanathanEmory University, Department of Biomedical Engineering, GA, USA.
Kaustav BeraUniversity Hospitals Cleveland Medical Center, Department of Radiology, Cleveland, OH, USA.
Rakesh ShiradkarEmory University, Department of Biomedical Engineering, GA, USA.
Lei YuanRenmin Hospital of Wuhan University, Department of Information Center, Wuhan, Hubei, China.
Keith ArmitageUniversity Hospitals Cleveland Medical Center, Department of Infectious Diseases, Cleveland, OH, USA.
Robert GilkesonUniversity Hospitals Cleveland Medical Center, Department of Radiology, Cleveland, OH, USA.
Mengyao JiRenmin Hospital of Wuhan University, Department of Gastroenterology, Wuhan, Hubei, China.
Pingfu FuCase Western Reserve University, Department of Population and Quantitative Health Sciences, Cleveland, OH, USA.
Amit GuptaUniversity Hospitals Cleveland Medical Center, Department of Radiology, Cleveland, OH, USA.
Cheng LuGuangdong Provincial People's Hospital, Department of Radiology, Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Provincial People's Hospital, Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Provincial People's Hospital, Medical Research Center, Guangdong Academy of Medical Sciences, China.
Anant MadabhushiGeorgia Institute of Technology and Emory University, Radiology and Imaging Sciences, Biomedical Informatics (BMI) and Pathology, GA, USA; Atlanta Veterans Administration Medical Center, GA, USA. Electronic address: anantm@emory.edu.

Funding

Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2020 to 2024
$5.0M
Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
Prognostic and Predictive Digital Tissue Image Assay for Prostate CancerR01CA268287 · NCI · EMORY UNIVERSITY · PI GUPTA, SHILPA, LAL, PRITI · 2022 to 2025
$3.0M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATIONR01HL158071 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BARNARD, JOHN, CHUNG, MINA KAY · 2021 to 2024
$2.9M
Novel Radiomics for Predicting Response to Immunotherapy for Lung CancerR01CA257612 · NCI · EMORY UNIVERSITY · PI Anant Madabhushi, Vamsidhar Velcheti · 2021 to 2026
$2.7M
An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic BenefitU01CA269181 · NCI · EMORY UNIVERSITY · PI Anant Madabhushi, tanuja shet · 2022 to 2026
$2.5M
BLRD VA I01 BX004121BLRD VA IK6 BX006185CSRD VA I01 CX002622CSRD VA I01 CX002776NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R01 CA257612NCI NIH HHS R01 CA268207NCI NIH HHS R01 CA268287NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U01 CA269181NCI NIH HHS U54 CA254566NCRR NIH HHS C06 RR012463NHLBI NIH HHS R01 HL151277NHLBI NIH HHS R01 HL158071NIBIB NIH HHS R43 EB028736
6 · The paper itself

Abstract

Severe COVID-19 can lead to extensive lung disease causing lung architectural distortion. In this study we employed machine learning and statistical atlas-based approaches to explore possible changes in lung shape among COVID-19 patients and evaluated whether the extent of these changes was associated with COVID-19 severity. On a large multi-institutional dataset (N = 3443), three different populations were defined; a) healthy (no COVID-19), b) mild COVID-19 (no ventilator required), c) severe COVID-19 (ventilator required), and the presence of lung shape differences between them were explored using baseline chest CT. Significant lung shape differences were observed along mediastinal surfaces of the lungs across all severity of COVID-19 disease. Additionally, differences were seen on basal surfaces of the lung when compared between healthy and severe COVID-19 patients. Finally, an AI model (a 3D residual convolutional network) characterizing these shape differences coupled with lung infiltrates (ground-glass opacities and consolidation regions) was found to be associated with COVID-19 severity.

Indexed as

COVID-19Deep LearningLungSARS-CoV-2Severity of Illness IndexTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID38815485
PMCPMC11188049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.